Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes

Apr-21

Endocrinology Pharmacoepidemiology Virology and Immunisations

AUTHORS : Prof Neil Thomas, PhD, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK – Email: g.n.thomas@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/thomas-neil.aspx

JOURNAL : Journal of Clinical Endocrinology & Metabolism

REFERENCE: 106(5):1255-1268

DOI : 10.1210/clinem/dgab067

Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease